Japan's Taisho to acquire France's UPSA

19 December 2018 - Deborah Wilkes


Japan's Taisho Pharmaceutical is set to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA for USD1.6 billion.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: